Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II–III Breast Cancer: Treatment Intervals and Clinical Outcomes
Jean L. Wright(University of North Carolina at Chapel Hill), Beryl McCormick(Memorial Sloan Kettering Cancer Center), Kathryn Beal(Memorial Sloan Kettering Cancer Center), Kimberly J. Van Zee(Memorial Sloan Kettering Cancer Center), Clifford A. Hudis(American Society of Clinical Oncology), Peter G. Cordeiro(Memorial Sloan Kettering Cancer Center), Leah Ben‐Porat(Mayo Clinic)
International Journal of Radiation Oncology*Biology*Physics
September 13, 2007
Cited by 55
Related Papers
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k
Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
|JAMA|2017|2.3k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|1.6k